Literature DB >> 27602075

Safety and efficacy of etomidate and propofol anesthesia in elderly patients undergoing gastroscopy: A double-blind randomized clinical study.

Qing-Tao Meng1, Chen Cao2, Hui-Min Liu1, Zhong-Yuan Xia1, Wei Li1, Ling-Hua Tang1, Rong Chen1, Meng Jiang1, Yang Wu1, Yan Leng1, Chris C Lee3.   

Abstract

The aim of the present study is to compare the safety, efficacy and cost effectiveness of anesthetic regimens by compound, using etomidate and propofol in elderly patients undergoing gastroscopy. A total of 200 volunteers (65-79 years of age) scheduled for gastroscopy under anesthesia were randomly divided into the following groups: P, propofol (1.5-2.0 mg/kg); E, etomidate (0.15-0.2 mg/kg); P+E, propofol (0.75-1 mg/kg) followed by etomidate (0.075-0.1 mg/kg); and E+P, etomidate (0.075-0.01 mg/kg) followed by propofol (0.75-1 mg/kg). Vital signs and bispectral index were monitored at different time points. Complications, induction and examination time, anesthesia duration, and recovery and discharge time were recorded. At the end of the procedure, the satisfaction of patients, endoscopists and the anesthetist were evaluated. The recovery (6.1±1.2 h) and discharge times (24.8±2.8 h) in group E were significantly longer compared with groups P, P+E and E+P (P<0.05). The occurrence of injection pain in group P+E was significantly higher compared with the other three groups (P<0.05). In addition, the incidence of myoclonus and post-operative nausea and vomiting were significantly higher in group P+E compared with the other three groups (P<0.05). There was no statistical difference among the four groups with regards to the patients' immediate, post-procedure satisfaction (P>0.05). Furthermore, there was no difference in the satisfaction of anesthesia, as evaluated by the anesthetist and endoscopist, among the four groups (P>0.05). The present study demonstrates that anesthesia for gastroscopy in elderly patients can be safely and effectively accomplished using a drug regimen that combines propofol with etomidate. The combined use of propofol and etomidate has unique characteristics which improve hemodynamic stability, cause minimal respiratory depression and less side effects, provide rapid return to full activity and result in high levels of satisfaction.

Entities:  

Keywords:  anesthesia; elderly patients; etomidate; gastroscopy; propofol

Year:  2016        PMID: 27602075      PMCID: PMC4998221          DOI: 10.3892/etm.2016.3475

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  25 in total

1.  Cardiopulmonary complications of ERCP in older patients.

Authors:  Leon Fisher; Alexander Fisher; Andrew Thomson
Journal:  Gastrointest Endosc       Date:  2006-06       Impact factor: 9.427

2.  Target-controlled infusion during monitored anesthesia care in patients undergoing EUS: propofol alone versus midazolam plus propofol. A prospective double-blind randomised controlled trial.

Authors:  L Fanti; M Agostoni; P G Arcidiacono; A Albertin; G Strini; S Carrara; M Guslandi; G Torri; P A Testoni
Journal:  Dig Liver Dis       Date:  2006-10-16       Impact factor: 4.088

3.  Adrenocortical dysfunction following etomidate induction in emergency department patients.

Authors:  C L Schenarts; J H Burton; R R Riker
Journal:  Acad Emerg Med       Date:  2001-01       Impact factor: 3.451

4.  A comparison of anesthetic regimens using etomidate and propofol in patients undergoing first-trimester abortions: double-blind, randomized clinical trial of safety and efficacy.

Authors:  Jing Wu; Shanglong Yao; Zhouyang Wu; Zhiling Wu; Shujuan Chu; Geqing Xia; Feitao Deng
Journal:  Contraception       Date:  2012-09-17       Impact factor: 3.375

5.  The effect of repeated etomidate anesthesia on adrenocortical function during a course of electroconvulsive therapy.

Authors:  Ning Wang; Xiao Hai Wang; Jun Lu; Jian You Zhang
Journal:  J ECT       Date:  2011-12       Impact factor: 3.635

6.  Modeling the non-steady state respiratory effects of remifentanil in awake and propofol-sedated healthy volunteers.

Authors:  Erik Olofsen; Merel Boom; Diederik Nieuwenhuijs; Elise Sarton; Luc Teppema; Leon Aarts; Albert Dahan
Journal:  Anesthesiology       Date:  2010-06       Impact factor: 7.892

7.  Adrenocortical function in critically ill patients 24 h after a single dose of etomidate.

Authors:  A Absalom; D Pledger; A Kong
Journal:  Anaesthesia       Date:  1999-09       Impact factor: 6.955

8.  Pretreatment with dexmedetomidine or thiopental decreases myoclonus after etomidate: a randomized, double-blind controlled trial.

Authors:  Ayse Mizrak; Senem Koruk; Murat Bilgi; Betul Kocamer; Ibrahim Erkutlu; Suleyman Ganidagli; Unsal Oner
Journal:  J Surg Res       Date:  2009-08-19       Impact factor: 2.192

9.  Heart Rate and Blood Pressure Changes during Gastroscopy in Healthy Older Subjects.

Authors:  Ruth Ross; Julia L Newton
Journal:  Gerontology       Date:  2004 May-Jun       Impact factor: 5.140

10.  The use of propofol as a sedative agent in gastrointestinal endoscopy: a meta-analysis.

Authors:  Daorong Wang; Chaowu Chen; Jie Chen; Yaxiang Xu; Lu Wang; Zhen Zhu; Denghao Deng; Juan Chen; Aihua Long; Dong Tang; Jun Liu
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

View more
  9 in total

1.  Etomidate Sedation for Advanced Endoscopic Procedures.

Authors:  Su Jung Han; Tae Hoon Lee; Jae Kook Yang; Young Sin Cho; Yunho Jung; Il-Kwun Chung; Sang-Heum Park; Suyeon Park; Sun-Joo Kim
Journal:  Dig Dis Sci       Date:  2018-07-27       Impact factor: 3.199

2.  Sevoflurane may be more beneficial than propofol in patients receiving endoscopic variceal ligation and endoscopic variceal sclerotherapy: A randomized, double-blind study.

Authors:  Linghua Tang; Huimin Liu; Yang Wu; Mei Li; Wei Li; Meng Jiang; Jiabao Hou; Ying Jiang; Zhongyuan Xia; Qingtao Meng
Journal:  Exp Ther Med       Date:  2017-08-09       Impact factor: 2.447

Review 3.  Dexmedetomidine Based Sedation for Post-surgery Critically Ill Adults: A Meta-analysis of Randomized Controlled Trials.

Authors:  Heng Fan; Yu Zhao; Min Sun; Ji-Hui Ye; Guo-Dong Chen; Jian-Hua Zhu
Journal:  Iran J Public Health       Date:  2017-12       Impact factor: 1.429

4.  Propofol protects against blood-spinal cord barrier disruption induced by ischemia/reperfusion injury.

Authors:  Li-Jie Xie; Jin-Xiu Huang; Jian Yang; Fen Yuan; Shuang-Shuang Zhang; Qi-Jing Yu; Ji Hu
Journal:  Neural Regen Res       Date:  2017-01       Impact factor: 5.135

5.  Effects of small-dose remifentanil combined with index of consciousness monitoring on gastroscopic polypectomy: a prospective, randomized, single-blinded trial.

Authors:  Minqiang Liu; Hongyan Wu; Danling Yang; Fengxian Li; Zhichao Li; Song Wang; Renliang He
Journal:  Trials       Date:  2018-07-18       Impact factor: 2.279

6.  Safety and efficacy of combined use of propofol and etomidate for sedation during gastroscopy: Systematic review and meta-analysis.

Authors:  Lingyuan Chen; Xueyan Liang; Xinmei Tan; Haibin Wen; Junsong Jiang; Yan Li
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Using Etomidate and Midazolam for Screening Colonoscopies Results in More Stable Hemodynamic Responses in Patients of All Ages.

Authors:  Jung Min Lee; Geeho Min; Bora Keum; Jae Min Lee; Seung Han Kim; Hyuk Soon Choi; Eun Sun Kim; Yeon Seok Seo; Yoon Tae Jeen; Hoon Jai Chun; Hong Sik Lee; Soon Ho Um; Chang Duck Kim
Journal:  Gut Liver       Date:  2019-11-15       Impact factor: 4.519

8.  Effective Doses of Nalbuphine Combined With Propofol for Painless Gastroscopy in Adults: A Randomized Controlled Trial.

Authors:  Shuangfeng Li; Ying Wang; Xiaojian Chen; Tingwan Huang; Na Li
Journal:  Front Pharmacol       Date:  2021-12-01       Impact factor: 5.810

9.  Efficacy and safety of etomidate-midazolam for screening colonoscopy in the elderly: A prospective double-blinded randomized controlled study.

Authors:  Jung Min Lee; Geeho Min; Jae Min Lee; Seung Han Kim; Hyuk Soon Choi; Eun Sun Kim; Bora Keum; Yoon Tae Jeen; Hoon Jai Chun; Hong Sik Lee; Chang Duck Kim; Jong-Jae Park; Beom Jae Lee; Seong Ji Choi; Woojung Kim
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.